Login / Signup

Response Evaluation Criteria in Solid Tumors (RECIST) following neoadjuvant chemotherapy in osteosarcoma.

Lillian M GuentherR Grant RowePatricia T AcharyaDavid W SwensonStephanie C MeyerCatherine M ClintonDongjing GuoMadhumitha SridharanWendy B LondonHolcombe E GrierKirsten EcklundKatherine A Janeway
Published in: Pediatric blood & cancer (2017)
PD by RECIST predicts poor outcome in localized disease patients. In bone lesions, chemotherapy proven to improve overall survival does not result in radiographic responses as measured by RECIST. Further investigation of RECIST in pulmonary metastatic disease in osteosarcoma is needed.
Keyphrases